INDEPENDENT ASSESSMENT
AU-0806 Fund I, a series of Vitalstage Ventures, LP is a compact 2026 venture vehicle whose SEC filing is unusually revealing because the entire stated offering had already been sold when the notice became effective. The Delaware limited partnership reported a September 11, 2026 first sale and a September 15 Form D filing covering exactly $1,000,000 offered, $1,000,000 sold and $0 remaining. Twenty-two investors participated and the minimum investment reported for an outside investor was $1,000. The issuer selected both Pooled Investment Fund and Venture Capital Fund, offered pooled investment fund interests, relied on Rule 506(b), claimed the Section 3(c)(1) exclusion and stated that the offering was not expected to continue beyond one year. No commissions or finder fees were reported. Those facts make AU-0806 materially different from an open-ended flagship fund: the public record shows a finite, fully subscribed capital pool with a relatively broad investor count for a $1 million vehicle rather than an indefinite fundraising program.
The legal structure requires more care than the VitalStage name alone suggests. The Form D identifies Fund GP, LLC as general partner and Belltower Fund Group, Ltd. only as the agent of the issuer's general partner. Abraham Wilson signed as an authorized person of that agent. Belltower therefore should not be described as VitalStage's investment manager, sponsor or portfolio decision-maker merely because it appears as a related person in the filing. Belltower publicly describes itself as a technology-enabled venture-fund administrator that originated from AngelList's fund-administration operation and now provides partnership accounting, investor onboarding, tax-document support, fund launches, capital activity and other back-office services to venture managers. The Form D itself reinforces that operational interpretation: Item 16 estimates an $8,000 payment to the fund administrator and/or its affiliates for administrative expenses covering the life of the vehicle. That $8,000 equals 0.8% of the $1 million offering, providing an unusually concrete public view of at least one layer of the SPV's organizational cost.
THE DISTINCTIVE STORY: TWO DIFFERENT VITALSTAGE STRUCTURES
The most important diligence point is that the VitalStage name appears across more than one legal architecture. AU-0806 uses the broad issuer name "a series of Vitalstage Ventures, LP," with Fund GP, LLC and Belltower visible in the regulatory record. By contrast, VitalStage Ventures Paradigm AI Fund, LP - I uses a dedicated VitalStage Ventures Paradigm AI GP I structure and directly identifies Brian Shin as manager of the general partner. A separate Fund II, a Series of VitalStage Ventures Paradigm AI Fund, LP was formed in 2026 with VitalStage Ventures Paradigm AI GP II, LLC as general partner and Brian Shin again identified as manager of the GP. Fund II filed on February 9, 2026 as a venture capital fund under Rule 506(b) and Section 3(c)(1), but at that filing date reported no first sale, $0 sold and zero investors. The contrast is useful: the Paradigm funds expose direct VitalStage investment-management personnel in their SEC records, while AU-0806 exposes a generic series GP plus Belltower's administrative layer.
The broader filing history shows that this use of series structures predates the current AI branding. SEC records identify AR Fund I, a series of Vitalstage Ventures, LP in 2020 and AR Fund II in 2022, both using earlier versions of the Seattle/Belltower operational infrastructure. Those filings likewise named Fund GP and Belltower-related entities in administrative or GP-management roles. More recently, VitalStage's Paradigm AI umbrella produced dedicated AI-focused entities, and a 2025 filing created BeamSPV, a series of VitalStage Ventures Paradigm AI Fund, LP. Taken together, these records show that "VitalStage Ventures" should not be treated as one single legal fund. It is better understood as a brand and investment platform around which multiple limited partnerships, series, GPs and special-purpose vehicles have been created over time.
AI STRATEGY AND MANAGER-LEVEL EVIDENCE
VitalStage's public-facing identity has evolved toward an explicitly AI-native venture strategy. Its official website describes the firm as an AI-native venture investor focused on responsible AI innovation and says the team invests at the seed stage. The firm states that its members have backed more than 50 technology companies, citing companies such as HubSpot, Lightmatter, Drift, HqO and Kayak as examples from the team's broader investment history. Brian Shin is identified as Managing Partner, with Fumi Matsumoto and Waikit Lau serving as Venture Partners and an advisory group including executives with experience at Google Labs, Dropbox and AWS. These facts provide meaningful manager-level context, but they should not be read as evidence that AU-0806 owns any of those companies. The AU-0806 Form D does not disclose its portfolio company, investment thesis, security type at the underlying-company level or valuation.
VitalStage has separately described its Paradigm AI Fund I as a seed fund for AI-native startups focused on AI infrastructure and applications capable of disrupting large incumbents. In 2025 the firm stated publicly that the Paradigm AI strategy had backed 17 AI startups. That is useful evidence of the investment team's thematic direction, particularly when paired with the SEC classification of the Paradigm vehicles as venture capital funds. It remains a platform-level statement rather than an AU-0806 asset list. The existence of BeamSPV under the Paradigm AI umbrella adds another structural clue: VitalStage can use dedicated SPVs alongside broader venture funds, allowing investors to access specific opportunities through separate legal series. Again, no public filing reviewed establishes that AU-0806 corresponds to Beam or to any particular named startup.
BELLTOWER IS AN OPERATING LAYER, NOT THE INVESTMENT BRAND
The Belltower connection deserves independent treatment because it explains why the legal address and signatory trail do not look like VitalStage's public website. Belltower states that it was established in 2019 from AngelList's fund-administration operation and now supports venture funds using AngelList's software infrastructure. Its current website reports more than 27,000 administered funds, more than 128,000 investment entities and clients representing over $25 billion of committed capital under administration. Those numbers describe Belltower's administration business across all clients and have nothing to do with the assets of VitalStage or AU-0806. What they do explain is why many unrelated venture SPVs can share Fund GP, Belltower personnel, Seattle/Lynnwood operational addresses and similar Form D formatting. Shared administrative infrastructure is therefore not evidence that those unrelated funds share investment management.
This distinction is particularly important for entity penetration. An investor searching only the AU-0806 SEC address reaches a Lynnwood administrative location, while VitalStage's current public website lists San Francisco and Reno as firm locations and the Paradigm AI filings use Reno for Brian Shin and their dedicated GPs. That difference is not by itself evidence of a problem; it is consistent with a fund being administered through a third-party platform while investment personnel operate elsewhere. But investors should obtain the subscription documents to confirm exactly which entity exercises investment discretion, which party is administrator, who controls the GP, where cash is custodied and whether VitalStage or another affiliated entity receives management fees or carried interest.
CAPITAL STRUCTURE, CONCENTRATION AND UNANSWERED QUESTIONS
AU-0806's small size creates a different risk profile from a large diversified venture fund. One million dollars divided among 22 reported investors implies a relatively modest average subscription if capital were evenly distributed, although the actual allocations are not disclosed and may vary significantly. The $1,000 minimum is also unusual for a private venture vehicle but should not be interpreted as evidence that the offering was generally available to the retail public: the fund relied on Rule 506(b) and Section 3(c)(1), and the Form D does not establish broad public eligibility. Because the entire $1 million offering was already sold and no amount remained, the vehicle appears economically closed at the filing date unless its terms are later amended.
The major information gap is the underlying asset. Public records reviewed here do not disclose whether AU-0806 owns shares in one private company, several companies, a secondary interest, a SAFE, a convertible instrument or another pooled vehicle. They also do not reveal entry valuation, ownership percentage, management fee, carried interest, distribution waterfall, follow-on reserve, expected duration, transfer rights, valuation methodology, custodian, audit arrangements or exit strategy. Given the series/SPV structure and short offering duration, a concentrated investment is plausible, but it should not be asserted without fund-specific documentation. Investors should request the subscription agreement, series supplement, investment memorandum, partnership agreement, fee schedule, underlying-company capitalization information, administrator confirmation and distribution mechanics.
FINAL ASSESSMENT
AU-0806 Fund I provides an unusually clear example of why private-fund diligence must separate the investment brand from the legal and administrative structure. The SEC filing verifies a fully subscribed $1 million venture fund with 22 investors, a September 2026 first sale, Rule 506(b), Section 3(c)(1), Fund GP, LLC as general partner and Belltower Fund Group as agent of that GP. Separate filings demonstrate that VitalStage also operates dedicated Paradigm AI funds in which Brian Shin and VitalStage-specific GPs are directly identified, while historical AR Fund I and AR Fund II filings show that the wider VitalStage series architecture predates the current Paradigm AI strategy.
The evidence therefore supports a real and continuing VitalStage fund ecosystem, but it does not justify collapsing every VitalStage-named series into one portfolio or treating Belltower as the investment manager. AU-0806's most important unresolved fact is still its underlying investment. Until the series-specific offering documents identify that asset and explain fees, control and economics, the strongest public conclusion is structural: this is a completed $1 million venture offering operated through a third-party administrative architecture within the wider VitalStage-named series ecosystem. Form D is an exempt-offering notice, not SEC approval, and neither the VitalStage brand nor Belltower's administrative scale establishes the investment quality or future return of AU-0806.